Skip Navigation


NDT Advance Access originally published online on February 10, 2008
Nephrology Dialysis Transplantation 2008 23(7):2260-2264; doi:10.1093/ndt/gfm946
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/7/2260    most recent
gfm946v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ng, D. P. K.
Right arrow Articles by Krolewski, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, D. P. K.
Right arrow Articles by Krolewski, A. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Genetic variation at the SLC12A3 locus is unlikely to explain risk for advanced diabetic nephropathy in Caucasians with type 2 diabetes

Daniel P. K. Ng1,2, Siti Nurbaya2, Serena Choo2, David Koh1,2, Kee-seng Chia1,2 and Andrzej S. Krolewski3,4

1 Department of Community, Occupational and Family Medicine 2 Centre for Molecular Epidemiology, National University of Singapore, Singapore 3 Section on Genetics and Epidemiology, Joslin Diabetes Center 4 Department of Medicine, Harvard Medical School, Boston, MA, USA

Correspondence and offprint requests to: Daniel P. K. Ng, Department of Community, Occupational and Family Medicine, National University of Singapore, Singapore. E-mail: cofnpkd{at}nus.edu.sg



  Abstract

Background. Large-scale genotyping efforts performed on Japanese subjects with type 2 diabetes have implicated polymorphisms in solute carrier family 12 (sodium/chloride transporters) member 3 (SLC12A3) as being associated with advanced diabetic nephropathy. However, it is not known whether these polymorphisms confer a risk for this complication in type 2 diabetic Caucasians.

Methods. A case-control study was conducted that consisted of 295 cases with advanced diabetic nephropathy and 174 controls who have remained normoalbuminuric despite ≥7 years of diabetes. A total of 11 single nucleotide polymorphisms (SNPs) spanning the SLC12A3 locus was analysed including +34372G>A (Arg913Gln) that was the marker previously showing the strongest evidence for disease association in type 2 diabetic Japanese. Power calculations indicated that with an alpha of 0.05, our study has >90% power to detect disease associations of the magnitude previously reported for +34372G>A (Arg913Gln).

Results. Allele and genotype distributions for all 11 SNPs were found to be comparable between cases and controls, consistent with the absence of disease association. This negative result was reiterated in subgroup analysis after taking into account potentially important covariates including gender, diabetes duration, blood pressure and glycaemic control. No significant disease associations were likewise found for SLC12A3 haplotypes. Allele, genotype and haplotype distributions were similar in cases regardless of whether they were proteinuric or had developed chronic renal failure/end-stage renal disease.

Conclusions. Genetic variation at the SLC12A3 locus is unlikely to explain the risk for advanced diabetic nephropathy among type 2 diabetic Caucasians.

Keywords: end-stage renal disease; genetic susceptibility; haplotype block; multiple hypothesis testing; proteinuria

Received for publication: 12.10.07
Accepted in revised form: 19.12.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
F. Pesce and F. P. Schena
Genome-wide association studies in kidney diseases: Quo Vadis?
Nephrol. Dial. Transplant., September 3, 2009; (2009) gfp442v1.
[Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
S. Maeda
Review: Genetics of diabetic nephropathy
Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 363 - 371.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.